NXU:XETRA Nexus AG

EUR 53.00 -0.30 -0.562852
Icon

Nexus AG (NXU:XETRA) Stock Analysis and Price Targets

COMMON STOCK | Health Information Services | XETRA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 53.00

-0.30 (-0.56)%

EUR 0.91B

5.50K

N/A

N/A

Icon

NXU:XETRA

Nexus AG (EUR)
COMMON STOCK | XETRA
EUR 53.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.91B

N/A

EUR 53.00

Nexus AG (NXU:XETRA) Stock Forecast

N/A

Based on the Nexus AG stock forecast from 0 analysts, the average analyst target price for Nexus AG is not available over the next 12 months. Nexus AG’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Nexus AG is Slightly Bullish , which is based on 10 positive signals and 6 negative signals. At the last closing, Nexus AG’s stock price was EUR 53.00. Nexus AG’s stock price has changed by -4.16% over the past week, -4.16% over the past month and +7.61% over the last year.

No recent analyst target price found for Nexus AG
No recent average analyst rating found for Nexus AG

Company Overview Nexus AG

Nexus AG develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally. The company operates through NEXUS / DE; NEXUS / DIS; and NEXUS / ROE segments. It offers hospital infor...Read More

https://www.nexus-ag.de

Irmastrasse 1, Donaueschingen, Germany, 78166

1,930

December

EUR

Germany

Adjusted Closing Price for Nexus AG (NXU:XETRA)

Loading...

Unadjusted Closing Price for Nexus AG (NXU:XETRA)

Loading...

Share Trading Volume for Nexus AG Shares

Loading...

Compare Performance of Nexus AG Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for NXU:XETRA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Nexus AG (Sector: Health Information Services )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
COP:XETRA
CompuGroup Medical SE & Co. KG.. +0.06 (+0.21%) EUR1.52B 33.11 10.79

ETFs Containing NXU

Symbol Name NXU's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Nexus AG (NXU:XETRA) Stock

Stock Target Advisor's fundamental analysis for Nexus AG's stock is Slightly Bullish .

NXU:XETRA stock's dividend yield is 0.41%. Our analysis grades NXU:XETRA stock's dividend yield at F. This means that NXU:XETRA stock's dividend yield is above 25% of the stocks in the Health Information Services sector in the XETRA exchange. Based on this NXU:XETRA may be a poor dividend stock for its sector.

Unfortunately we do not have enough data on NXU:XETRA's stock to indicate what its average analyst target is.

NXU:XETRA stock's Price/Earning ratio is 38.06. Our analysis grades NXU:XETRA stock's Price / Earning ratio at F. This means that NXU:XETRA stock's Price/Earning ratio is above 75% of the stocks in the Health Information Services sector in the XETRA exchange. Based on this NXU:XETRA may be a overvalued for its sector.

The last closing price of NXU:XETRA's stock was EUR 53.00.

The most recent market capitalization for NXU:XETRA is EUR 0.91B.

Unfortunately we do not have enough analyst data on NXU:XETRA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Nexus AG's stock.

As per our most recent records Nexus AG has 1,930 Employees.

Nexus AG's registered address is Irmastrasse 1, Donaueschingen, Germany, 78166. You can get more information about it from Nexus AG's website at https://www.nexus-ag.de.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...